{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:40:09Z","timestamp":1758973209802,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.annder.2020.06.012","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T08:08:30Z","timestamp":1595318910000},"page":"582-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vasculite leucocytoclasique sous pembrolizumab"],"prefix":"10.1016","volume":"147","author":[{"given":"C.","family":"Wirbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Balme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2020.06.012_bib0030","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s10067-018-4177-0","article-title":"Vasculitis associated with immune checkpoint inhibitors \u2013 a systematic review","volume":"37","author":"Daxini","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.annder.2020.06.012_bib0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jdcr.2018.03.013","article-title":"Nivolumab \u2013 induced systemic vasculitis","volume":"4","author":"Kang","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2020.06.012_bib0040","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jdcr.2018.05.020","article-title":"Checkpoint inhibitor \u2013 associated cutaneous small vessel vasculitis","volume":"4","author":"Castillo","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2020.06.012_bib0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.11604\/pamj.2017.26.138.9721","article-title":"Vascularites cutan\u00e9es leucocytoclasiques\u00a0: \u00e0 propos de 85\u00a0cas","volume":"26","author":"Aounallah","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.annder.2020.06.012_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.21037\/tlcr.2020.03.01","article-title":"IgA vasculitis and polymyalgia rheumatica induced by durvalumab","volume":"9","author":"Casafont-Sol\u00e9","year":"2020","journal-title":"Transl Lung Cancer Res"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963820302672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963820302672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:09:55Z","timestamp":1758971395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963820302672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":5,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0151963820302672"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2020.06.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasculite leucocytoclasique sous pembrolizumab","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2020.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}